Accelario

About
What does Accelario do?
Accelario provides a unique Test Data Management (TDM) platform designed to accelerate data delivery for DevOps, R&D, and QA teams. It aims to significantly reduce costs and eliminate the need for specialized engineering skills, supporting leading databases and CI/CD tools.
What is Accelario's revenue?
StartupHub estimates Accelario's annual revenue at $2.3M (range $1.4M to $4.4M, 71% confidence), based on comparable companies in the sector.
Where is Accelario headquartered?
Accelario is headquartered in Tel Aviv, Israel.
When was Accelario founded?
Accelario was founded in 2016.
What industry does Accelario operate in?
Accelario operates in Enterprise, Data, Synthetic Data, DataOps, CI/CD, Data Management.
How many employees does Accelario have?
Accelario has approximately 17 people on record.
Does Accelario have an affiliate program?
Yes, Accelario has an affiliate program. The program runs on Self-hosted affiliate. Register here: https://www.accelario.com/affiliates
AI-powered platform for operational records, scope boundaries, review notes, and repeatable checks.
Cxtc provides a platform for operational record management, scope definition, and repeatable checks.
Bellingbio provides a platform for managing technical records, sample boundaries, review notes, trace points, and repeatable checks.
Cytosine is an AI company developing a platform to automate and optimize the creation of AI models.
Dattic provides an AI-powered data platform that helps businesses understand and utilize their data for better decision-making.
Dataworthy provides a platform for data discovery and understanding, enabling teams to find and use data effectively.
Kandinskydata provides a platform for generating synthetic data for AI model training and testing.
An entrant is a company tagged DataOps whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.